← Open Payments lookup

NPI 1346241395: Open Payments

NPI 1346241395. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$331 in 13 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $389 · 2025 $331

Food & beverage: $331
CompanyPaymentsAmount
Kestra Medical Technology Services, Inc.4$127
Merck Sharp & Dohme LLC3$80
Novartis Pharmaceuticals Corporation2$32
GlaxoSmithKline, LLC.1$31
Boston Scientific Corporation1$29
Inspire Medical Systems, Inc.1$16
Bayer Healthcare Pharmaceuticals Inc.1$15

Products named: Assure WCD, VERQUVO, LEQVIO, AREXVY, WATCHMAN, INSPIRE, Kerendia.